glp-1 doctor san francisco Weight Loss Younan Nowzaradan, aka Dr. Now

respectively) (Table 1)

The once-daily human GLP-1 analogue liraglutide impacts appetite and energy intake in patients with type 2 diabetes after short-term treatment

10.1073/pnas.100129497 364

Cardiovascular Effects of GLP-1 Receptor Agonists A significant body of preclinical research has illuminated the beneficial impact of GLP-1 RAs on endothelial function, largely attributed to the widespread distribution of GLP-1 receptors on endothelial cells throughout different anatomical regions [108,109]

Clinical trials and real-world data consistently show: Average weight loss of 1520% on semaglutide or tirzepatide Improvements in blood pressure, cholesterol, and blood sugar Reduced risk of developing type 2 diabetes and cardiovascular disease These outcomes are meaningful both for employee health and long-term cost avoidance